Last updated 2026-06-18
- Raised funding round, Jan 2020
Total raised
—
Last: 2020-01
Stage
Seed
Founded
2019
Headcount
4
HQ
Tel Aviv-Yafo, Israel
Sector
Health Tech & Life Sciences
About
Xinteza is developing advanced proprietary biosynthesis and bioextraction technologies related to the production of cannabinoid-based active pharmaceutical ingredients (APIs) for the pharmaceutical and food industries.
The company is engaged in the research and discovery of a wide array of new genes and ultra-novel genetic paths for the biosynthesis of cannabinoids and psychoactive ingredients and the development of their bioproduction methods. Xinteza holds the exclusive license for both cannabinoids and psychoactives from the Weizmann Institute and is building an exceptional portfolio of dozens of related IP and patents.
Funding history · 1 round · — total
2020-01
Undisclosed
Q&A
- What is Xinteza API's primary business?
- Xinteza API is developing advanced proprietary biosynthesis and bioextraction technologies for producing cannabinoid-based active pharmaceutical ingredients (APIs) for the pharmaceutical and food industries.
- When was Xinteza API founded?
- Xinteza API was founded in March 2019.
- What is Xinteza API's current employee count?
- Xinteza API has 1-10 employees.
- What is Xinteza API's primary sector?
- Xinteza API's primary sector is Health Tech & Life Sciences.
- What is Xinteza API's current funding stage?
- Xinteza API is currently in the Seed funding stage.
- Does Xinteza API hold any patents?
- Yes, Xinteza API holds at least one patent and is building a portfolio of related IP and patents.
- What is the nature of Xinteza API's intellectual property?
- Xinteza API holds an exclusive license for cannabinoids and psychoactives from the Weizmann Institute and is developing a portfolio of related IP and patents.
- What is Xinteza API's product stage?
- Xinteza API is currently in the R&D product stage.
Team · 3
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyMedical Cannabis
Technologies
BiologicalsMoleculesGenes
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Highlights
1 Patents
Tags
natural-active-ingredientsagtechmedical-cannabisplant-genomicsapicannabispharmaceuticals
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | xinteza.com |
|---|---|
| linkedin.com/company/77669925 |
Identifiers & details
| Founded | 2019-3 |
|---|---|
| Employees (exact) | 4 |
Radar intelligence
Web history (Wayback)
| Domain | xinteza.com |
|---|
Certificate / subdomain footprint
| Subdomains | 3 |
|---|